BRKR * Stock Overview Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Bruker Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Bruker Historical stock prices Current Share Price US$1,249.00 52 Week High US$1,372.36 52 Week Low US$1,139.98 Beta 1.2 1 Month Change 0% 3 Month Change n/a 1 Year Change n/a 3 Year Change -24.85% 5 Year Change n/a Change since IPO 37.37%
Recent News & Updates
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility Dec 21
Bruker Corporation Introduces Dimension Nexus Atomic Force Microscope Dec 02
Bruker Corporation Announces Quarterly Dividend, Payable on December 16, 2024 Nov 19
Bruker Announces EpicIFTM, Fluorescence Signal Removal Technology, Transforming Cellscape Spatial Proteomics Platform Nov 08
Bruker Corporation Updates Earnings Guidance for the Fiscal Year 2024 Nov 05
Bruker Corporation to Report Q3, 2024 Results on Nov 05, 2024 Oct 29 See more updates
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility Dec 21
Bruker Corporation Introduces Dimension Nexus Atomic Force Microscope Dec 02
Bruker Corporation Announces Quarterly Dividend, Payable on December 16, 2024 Nov 19
Bruker Announces EpicIFTM, Fluorescence Signal Removal Technology, Transforming Cellscape Spatial Proteomics Platform Nov 08
Bruker Corporation Updates Earnings Guidance for the Fiscal Year 2024 Nov 05
Bruker Corporation to Report Q3, 2024 Results on Nov 05, 2024 Oct 29
Bruker Corporation Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging Oct 07
Bruker Corporation (NasdaqGS:BRKR) acquired Dynamic Biosensors GmbH. Oct 04
Bruker Corporation (NasdaqGS:BRKR) acquired Dynamic Biosensors GmbH. Oct 03
Insufficient new directors Aug 22
Bruker Corporation Announces Quarterly Cash Dividend, Payable on September 16, 2024 Aug 13
New major risk - Financial position Aug 07
Second quarter 2024 earnings released: EPS: US$0.052 (vs US$0.39 in 2Q 2023) Aug 07
Bruker Corporation to Report Q2, 2024 Results on Aug 06, 2024 Aug 01 Bruker Corporation Announces Suspension of Injunction Impacting NanoString's CosMx Spatial Molecular Imager Products in Germany Jul 18
Insufficient new directors Jul 16
Bruker Corporation Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie (FMP) in Berlin Jul 02 Bruker Corporation Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics Bruker Corporation has completed a Follow-on Equity Offering.
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024 May 16
Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. May 07
Bruker Corporation Revises Earnings Guidance for the Year 2024 May 03
Bruker Corporation to Report Q1, 2024 Results on May 02, 2024 Apr 28
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference Apr 27
Bruker Corporation, Annual General Meeting, May 30, 2024 Apr 21
Bruker Corporation (NasdaqGS:BRKR) entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. for approximately $390 million. Apr 19
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies Apr 09
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO Mar 12
Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Chemspeed Technologies AG. Mar 07
Tecfin S.À R.L. entered into an agreement to acquire Identicare Limited from Tecfin S.À R.L. for €870 million. Feb 28
Fourth quarter dividend of US$0.05 announced Feb 26
Bruker Corporation Approves Payment of A Quarterly Cash Dividend, Payable on March 15, 2024 Feb 17
Full year 2023 earnings released: EPS: US$2.92 (vs US$2.00 in FY 2022) Feb 14
Insufficient new directors Feb 14
Bruker Corporation Provides Earnings Guidance for the Fiscal Year 2024 Feb 14
Bruker Corporation (NasdaqGS:BRKR) acquired Nanophoton Corporation. Feb 08
Bruker Corporation to Report Q4, 2023 Results on Feb 13, 2024 Feb 07
Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire Chemspeed Technologies AG. Jan 25
Bruker Corporation (NasdaqGS:BRKR) acquired Tornado Spectral Systems. Jan 05
Bruker Corporation Announces Quarterly Dividend, Payable on December 15, 2023 Nov 21
Bruker Corporation Revises Revenue Guidance for the Fiscal Year 2023 Nov 03
Bruker Corporation to Report Q3, 2023 Results on Nov 02, 2023 Oct 28
Bruker Corporation Introduces Next-Generation Nanomechanical Test System Oct 05
Bruker Introduces Novel 4D-Proteomics™ Timstof® Capabilities Sep 19
Bruker Corporation Provides Revenue Guidance for Fiscal Year 2023 Sep 16
Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL). Aug 19
Bruker Corporation Approves Payment of Quarterly Cash Dividend in on the Company’s Common Stock, Payable on September 15, 2023 Aug 15
Bruker Corporation Raises Financial Outlook for Fiscal Year 2023 Aug 04
Bruker Corporation to Report Q2, 2023 Results on Aug 03, 2023 Jul 26
Bruker Announces SciY Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries Jul 01
Bruker Corporation Announces New D6 PHASER Benchtop X-Ray Diffraction Platform for Materials Analysis and Advanced Research Jun 28 Bruker CorporationIntroduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
Bruker Corporation (NasdaqGS:BRKR) announces an Equity Buyback for $500 million worth of its shares. May 16
Bruker Corporation (NasdaqGS:BRKR) acquired ZONTAL, Inc. May 09
Bruker Corporation Raises Financial Outlook for Fiscal Year 2023 May 05
Bruker Corporation Approves Quarterly Dividend, Payable on March 17, 2023 Feb 18
Full year 2022 earnings released: EPS: US$2.00 (vs US$1.83 in FY 2021) Feb 10
Bruker Corporation Provides Revenue Guidance for Fiscal Year 2023 Feb 10
Bruker Corporation to Report Q4, 2022 Results on Feb 09, 2023 Feb 01
Bruker Corporation Provides Revenue Guidance for the Fourth Quarter of Fiscal Year 2022 and Full Fiscal Year 2023 Jan 10
Bruker Corporation (NasdaqGS:BRKR) acquired Acquifer Imaging Gmbh. Jan 07
Bruker Corporation (NasdaqGS:BRKR) acquired an unknown majority stake in Biognosys AG. Jan 05
Bruker Corporation (NasdaqGS:BRKR) acquired Neurescence Inc. Dec 06
Upcoming dividend of US$0.05 per share Nov 23
Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire Neurescence Inc. Nov 15
Bruker Corporation Announces Quarterly Dividend, Payable on December 16, 2022 Nov 12
Bruker Corporation (NasdaqGS:BRKR) acquired Inscopix, Inc. Nov 09
Third quarter 2022 earnings released: EPS: US$0.60 (vs US$0.57 in 3Q 2021) Nov 04 Bruker Corporation Provides Earnings Guidance for the Year of 2022 Nov 04
Bruker Corporation to Report Q3, 2022 Results on Nov 03, 2022 Oct 22
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software Aug 30
Upcoming dividend of US$0.05 per share Aug 24
Bruker Corporation Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations Aug 23
Bruker Approves Payment of Quarterly Cash Dividend, Payable September 16, 2022 Aug 13
Second quarter 2022 earnings released: EPS: US$0.33 (vs US$0.38 in 2Q 2021) Aug 04
Bruker Corporation Provides Earnings Guidance for the Year 2022 Aug 04
Bruker Corporation to Report Q2, 2022 Results on Aug 03, 2022 Jul 26
Bruker Corporation Launches NMR-Based Molecular Phenomics Clinical Research Tool for ‘Long Covid’ Multi-Organ Risk Assessment Jul 07
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions At Analytica 2022 Jun 22
Bruker Corporation Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope Jun 15
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics(TM) Jun 07
Bruker Corporation Announces Quarterly Cash Dividend, Payable on June 17, 2022 May 18 Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets May 10
Bruker Corporation (NasdaqGS:BRKR) acquired unknown minority stake in Tofwerk AG for CHF 18 million. May 08
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet Apr 26
Marc A. Kastner Intends to Retire from as Director of Bruker Corporation Apr 23 Shareholder Returns BRKR * MX Life Sciences MX Market 7D 0% 0% 0% 1Y n/a 0% 0%
See full shareholder returns
Return vs Market: Insufficient data to determine how BRKR * performed against the MX Market .
Price Volatility Is BRKR *'s price volatile compared to industry and market? BRKR * volatility BRKR * Average Weekly Movement n/a Life Sciences Industry Average Movement 0% Market Average Movement 0% 10% most volatile stocks in MX Market 0% 10% least volatile stocks in MX Market 0%
Stable Share Price: BRKR *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine BRKR *'s volatility change over the past year.
About the Company Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.
Show more Bruker Corporation Fundamentals Summary How do Bruker's earnings and revenue compare to its market cap? BRKR * fundamental statistics Market cap Mex$151.61b Earnings (TTM ) Mex$6.17b Revenue (TTM ) Mex$65.60b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) BRKR * income statement (TTM ) Revenue US$3.24b Cost of Revenue US$1.62b Gross Profit US$1.62b Other Expenses US$1.31b Earnings US$304.90m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 2.01 Gross Margin 49.95% Net Profit Margin 9.41% Debt/Equity Ratio 125.1%
How did BRKR * perform over the long term?
See historical performance and comparison Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/11/19 15:13 End of Day Share Price 2024/08/22 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Bruker Corporation is covered by 35 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Luke Sergott Barclays Michael Ryskin BofA Global Research Derik de Bruin BofA Global Research
Show 32 more analysts 